Cogent Biosciences, Inc. Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage
Cogent Biosciences, Inc. (COGT) reported Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage of 4.00% for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Notes › Compensation Related Costs
us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage · last filed 2021-05-12
- Cogent Biosciences, Inc. defined contribution plan, employers matching contribution, annual vesting percentage for the quarter ending 2021-03-31 was 4.00%.
| Period end | Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage 3 month |
|---|---|
| 2021-03-31 | 4.00% 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |